Paydirt
PS
Insider

Philip Astley-Sparke

Director

Philip Astley-Sparke (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Replimune Group, Inc. (REPL). The largest single filing was $260K of REPL (32,279 sh × $8.06, as filed), executed May 20 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$260K
shares × price, as filed
Last traded
May 20 2025
Filed May 22 2025

Median ADV $90.1M across their filed names

Open performance
Volume by month
$260K$130K$0Oct 2024Apr 2025Oct 2025Apr 2026May 2025 · sells $260K
Buys $0 Sells $260K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names
REPL Replimune Group, Inc. REPL · 0 buys · 1 sell 1 filing
Recent filings
REPLSALE Replimune Group, Inc. View filing → $260K
32,279 sh × $8.06
Exec May 20 2025
Filed May 22 2025 · 5:30 PM ET